Full-Time

Director – Quality Assurance

Posted on 6/13/2024

Karius

Karius

51-200 employees

Non-invasive diagnostic tests for infections

Biotechnology
Healthcare

Compensation Overview

$184.8k - $277.2kAnnually

Senior

San Carlos, CA, USA

Position requires onsite presence in Redwood City, CA.

Category
QA & Testing
Quality Assurance
Requirements
  • 8+ years of Quality Management, Quality Assurance, and Quality Control leadership experience in Diagnostics, Biotechnology, or relatable life sciences fields. Regulatory experience is highly preferred.
  • BS in molecular biology, microbiology or related field; advanced degree (MS/PhD) preferred.
  • Experience with implementation, management and operation of FDA-compliant and LDT quality systems. ISO 13485 experience a plus.
  • Experience in a quality assurance role, bringing an In-Vitro Diagnostic (IVD) product (or products) through the FDA process.
  • Experience preparing for and managing audit visits by certification bodies or regulators, demonstrated by successful completion of audits or successful certification.
  • Strong understanding of diagnostic assay development and production processes.
  • Demonstrated ability to lead cross-functional teams and manage complex projects in a fast-paced startup environment. Excellent communication and interpersonal skills.
Responsibilities
  • Define and build the quality team that will be needed to achieve company goals.
  • Lead the implementation, management, and operation of Karius’ quality function for compliance with both FDA-QSR and CLIA/CAP/NYSDOH.
  • Develop and plan innovative quality and regulatory strategies in life cycle product management for clinical metagenomic tests.
  • Manage all aspects of the quality assurance lifecycle including scheduling, planning, issuing agendas, executing, issuing reports, evaluating responses, requesting clarification, corrective and preventive actions (CAPA), and closing.
  • Promote awareness across the commercial and clinical manufacturing platform(s) of current regulatory agency requirements and trends and develop and report on the trends identified.
  • Ensure continuous improvement of the QA systems and processes, by establishing Key Performance Indicators to monitor compliance and efficiency.
  • Collaborate with R&D, product, manufacturing, clinical, and regulatory teams to ensure quality standards are integrated throughout the product life cycle.
  • Work closely with other departments to address quality issues and implement CAPA.
  • Ensure CAPA identified during audits to address compliance concerns identified during audits are commensurate with current industry practices and benchmarks.
  • Develop Karius’ global quality policy & standards, supporting the company mission to deliver unprecedented insight to enable clinicians to make rapid life-saving treatment decisions.
  • Act as technical expert in quality processes, guiding cross-functional teams in process development, evaluation, and continuous improvement.
  • Work across teams to ensure efforts are synchronized with Karius quality procedures, resulting in a single harmonized quality function for the company.
  • Lead batch record review, lot disposition, material release, internal audit program, deviation handling, change controls, and quality events processes.

Karius focuses on medical diagnostics for infectious diseases, offering the Karius Test, a liquid biopsy that detects over 1,000 pathogens from a single blood sample. This non-invasive test provides quick results, helping clinicians treat hospitalized patients without the need for multiple invasive tests that can delay care. The Karius Test utilizes advanced genomics and artificial intelligence to identify microbial cell-free DNA (mcfDNA) in the bloodstream, giving insights into the pathogens responsible for infections. Karius differentiates itself by providing a faster and less invasive alternative to traditional diagnostic methods, which can save lives and lower healthcare costs. The company continuously updates its machine learning algorithms and genomic databases to enhance its diagnostic capabilities, aiming to lead in the field of infectious disease diagnostics.

Company Stage

Series C

Total Funding

$311.3M

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

4%

1 year growth

20%

2 year growth

20%
Simplify Jobs

Simplify's Take

What believers are saying

  • Karius received FDA Breakthrough Device Designation for its test.
  • The company raised $100M to expand beyond 400 U.S. hospitals.
  • Experienced board members were appointed to strengthen strategic direction.

What critics are saying

  • Emerging competition from AI-driven technologies like DeepMind's AlphaFold 3.
  • Dependency on FDA approvals could delay market expansion.
  • Limited deployment in 400 healthcare institutions poses a partnership risk.

What makes Karius unique

  • Karius Test detects over 1,000 pathogens from a single blood sample.
  • The test uses AI to analyze microbial cell-free DNA for rapid diagnosis.
  • Karius offers a non-invasive alternative to traditional diagnostic methods.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE